Scholar Rock Holding Debt-to-Equity Ratio Growth & History (SRRK)
Scholar Rock Holding's debt-to-equity ratio was 0.44 for fiscal 2025.
View full Scholar Rock Holding company overviewScholar Rock Holding annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.44 | 0.27 | +151.13% |
| 2024 | 2024-12-31 | 0.18 | −0.10 | −35.64% |
| 2023 | 2023-12-31 | 0.27 | 0.01 | +2.93% |
| 2022 | 2022-12-31 | 0.27 | −0.18 | −40.45% |
| 2021 | 2021-12-31 | 0.45 | 0.23 | +104.37% |
| 2020 | 2020-12-31 | 0.22 | 0.17 | +366.50% |
| 2019 | 2019-12-31 | 0.05 | 0.05 | +20767.17% |
| 2018 | 2018-12-31 | 0.00 | — | — |
Scholar Rock Holding quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.80 | 0.54 | +204.53% |
| Q1 2026 | 2026-03-31 | 0.75 | 0.54 | +268.59% |
| Q4 2025 | 2025-12-31 | 0.44 | 0.27 | +151.13% |
| Q3 2025 | 2025-09-30 | 0.45 | −0.39 | −46.58% |
| Q2 2025 | 2025-06-30 | 0.26 | −0.25 | −48.21% |
| Q1 2025 | 2025-03-31 | 0.20 | −0.13 | −38.55% |
| Q4 2024 | 2024-12-31 | 0.18 | −0.10 | −35.64% |
| Q3 2024 | 2024-09-30 | 0.84 | 0.46 | +122.09% |
| Q2 2024 | 2024-06-30 | 0.51 | 0.19 | +57.66% |
| Q1 2024 | 2024-03-31 | 0.33 | 0.03 | +11.44% |
| Q4 2023 | 2023-12-31 | 0.27 | 0.01 | +2.93% |
| Q3 2023 | 2023-09-30 | 0.38 | 0.13 | +53.88% |
| Q2 2023 | 2023-06-30 | 0.32 | 0.10 | +44.07% |
| Q1 2023 | 2023-03-31 | 0.30 | −0.15 | −33.01% |
| Q4 2022 | 2022-12-31 | 0.27 | −0.18 | −40.45% |
| Q3 2022 | 2022-09-30 | 0.25 | −0.04 | −14.22% |
| Q2 2022 | 2022-06-30 | 0.22 | −0.03 | −12.27% |
| Q1 2022 | 2022-03-31 | 0.44 | 0.21 | +90.09% |
| Q4 2021 | 2021-12-31 | 0.45 | 0.23 | +104.37% |
| Q3 2021 | 2021-09-30 | 0.29 | −0.24 | −45.09% |
| Q2 2021 | 2021-06-30 | 0.26 | 0.20 | +341.00% |
| Q1 2021 | 2021-03-31 | 0.23 | 0.18 | +354.15% |
| Q4 2020 | 2020-12-31 | 0.22 | 0.17 | +366.50% |
| Q3 2020 | 2020-09-30 | 0.52 | 0.48 | +1043.16% |
| Q2 2020 | 2020-06-30 | 0.06 | 0.01 | +30.69% |
| Q1 2020 | 2020-03-31 | 0.05 | −0.01 | −16.57% |
| Q4 2019 | 2019-12-31 | 0.05 | 0.05 | +20767.17% |
| Q3 2019 | 2019-09-30 | 0.05 | 0.04 | +654.39% |
| Q2 2019 | 2019-06-30 | 0.04 | 0.04 | +577.02% |
| Q1 2019 | 2019-03-31 | 0.06 | — | — |
| Q4 2018 | 2018-12-31 | 0.00 | — | — |
| Q3 2018 | 2018-09-30 | 0.01 | — | — |
| Q2 2018 | 2018-06-30 | 0.01 | — | — |
Scholar Rock Holding debt-to-equity ratio trends
Over the last five fiscal years, Scholar Rock Holding's debt-to-equity ratio increased from 0.22 to 0.44, a change of 0.22. The latest reported quarter, Q2 2026, shows 0.80.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scholar Rock Holding source filings ↗Community posts
Scholar Rock wins FDA approval for muscle-targeted SMA treatment
Scholar Rock ($SRRK) received FDA approval for ISEMBYLD, its apitegromab treatment for spinal muscular atrophy, in patients aged two and older receiving SMN2-targeted therapy. The company plans to begin shipping the medicine within days. Th ...